Pharmaceutical St. John's Wort

Patent Pending Studies have supported the use of St John's wort as a treatment for depression in humans.[5][11] It is proposed that the mechanism of action of St. John's wort is due to the inhibition of reuptake of certain neurotransmitters.[2] A 2008 Cochrane review of 29 clinical trials concluded that it was superior to placebo in patients with major depression, as effective as standard antidepressants and had fewer side-effects.